Corresponding author: Hanna I. Severina ( severina.ai@ukr.net ) Academic editor: Plamen Peikov
© 2019 Hanna I. Severina, Olga O. Skupa, Natalya I. Voloshchuk, Marharyta M. Suleiman, Victoriya A. Georgiyants.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Severina HI, Skupa OO, Voloshchuk NI, Suleiman MM, Georgiyants VA (2019) Synthesis and anticonvulsant activity of 6-methyl-2-((2-oxo-2-arylethyl)thio)pyrimidin-4(3 H)-one derivatives and products of their cyclization. Pharmacia 66(3): 141-146. https://doi.org/10.3897/pharmacia.66.e38137
|
The alkylation of 6-methyl-2-thioxo-2,3-dihydro-1H-pyrimidine-4-one phenacyl bromides under different conditions was investigated. It was found that during the reaction in the medium of DMF/K2CO3 a mixture of 2-(2-aryl-2-oxoethyl)thio-6-methyl-pyrimidine-4(3H)-one and 3-hydroxy-3-aryl-7-methyl-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-5-one was formed. The holding of the resulting mixture in the concentrated sulphuric acid leads to the formation of cyclization products - derivatives of 3-aryl-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one with high yields. Individual S-alkylated derivatives – 2-(2-aryl-2-oxoethyl)thio-6-methyl-pyrimidine-4(3H)-one - were obtained by reacting in methanol in the presence of sodium methoxide. Pharmacological screening of synthesized compounds for anticonvulsant activity on the model of pentylenetetrazole seizures in rats was carried out and some regularity “structure-activity” was established.
synthesis, pyrimidine, thiazolopyrimidine, anticonvulsant activity
Derivatives of 2-thiouraсil are the subject of close attention of scientists from different countries, which is associated with a significant and varied spectrum of their biological activity. Its derivatives are known as antiviral (
The study of the influence of thiopyrimidines on the activity of the central nervous system continues to be one of the priority directions of research of this class of compounds, among which also has an anticonvulsant effect. The search for modern anticonvulsants, with fundamentally new mechanisms of action, remains an issue of the present day, since chronic and, especially, refractory forms of epilepsy are subjected to pharmacological correction with existing antiepileptic drugs (
Relying on its own positive experience with the search for anticonvulsants with a significant safety profile (
In this study, we aimed to synthesize derivatives of 6-methyl-2-[(2-oxo-2-arylethyl)thio]pyrimidin-4(3H)–one and [(4-methyl-6-oxo-1H-pyrimidine-2-yl)thio] methylphenyl acetate, which are structural analogues of the previously studied acetamides (Fig.
All solvents and reagents were obtained from commercial sources. The reactions were monitored by thin-layer chromatography (TLC) on Silufol UV-254 plates, ethyl acetate-hexane solvent system (1: 1), iodine vapor as developer. The melting point (°C) was determined in a capillary using the electrothermal digital apparatus IA9100X1 (Bibby Scientific Limited, Staffordshire, UK). 1H NMR spectra were recorded on a Varian Mercury-400 (Varian Inc., Palo Alto, CA, USA) spectrometer (400 MHz) in dimethyl sulfoxide (DMSO-d6) using tetramethylsilane (TMS) as an internal standard (chemical shifts in ppm). Elemental analysis were performed on a micro-analyzer Euro Vector EA-3000 (Eurovector SPA, Redavalle, Italy). Elemental analyzes were within ± 0.4% of theoretical values LC / MS was recorded using the RE SCIEX API 150EX chromatograph.
6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one(1)obtained by the method described in the literature (
General procedure for the synthesis of 2-(2-aryl-2-oxoethyl)thio-6-methylpyrimidin-4(3H)-one derivatives (3.1–3.7). 2 mmol of 2-thiouracil 1 was dissolved in 6 ml of anhydrous methanol and sodium methoxide (118 mg, 2.2 mmol) was added followed by 2.2 mmol of the corresponding phenacyl bromide 2. The mixture was stirred for 1 hour and 10 ml of water was added. The precipitate was filtered off, dried and recrystallized from a mixture of acetone and DMF.
6-Methyl-2-[(2-oxo-2-phenylethyl)thio]pyrimidin-4(3H)-one (3.1).
Yield – 82%, m.p. = 182–4 °C. 1HNMR (400 MHz, DMSO-d6):12.55 (br. s, 1Н, NH-3), 8.08 (d, J 7.5Hz, 2H, H-2’,6’), 7.69 (t, J 7.2 Hz, 2H, H-3’,5’), 7.53 (t, J 7.5 Hz, 1H, H-4’), 5.96 (s, 1H, CH-5), 4.74 (s, 2H, SCH2), 1.95 (s, 3H, CH3). Found, m/z: 261,2 [M+H]+. Anal. Calcd for C13H12N2O2S:C 59.98, Н 4.65, N 10.76, S 12.32. Found: C 56.75, Н 4.63, N 10.76,S 12. 27.
2-([2-(4-Bromophenyl)-2-oxoethyl]thio)-6-methylpyrimidin-4(3H)-one (3.2) [19].
Yield – 75%, m.p. = 160–2 °C.1HNMR (400 MHz, DMSO-d6): 12.52 (br. s, 1Н, NH-3), 7.98 (d, J8.4 Hz, 2H, H-2’,6’), 7.79 (d, J 8.4 Hz, 2H, H-3’,5’), 5.96 (s, 1H, CH-5), 4.71 (s, 2H, SCH2), 1.95 (s, 3H, CH3). Found, m/z: 339,90 [M+H]+. Anal. Calcd for C13H11BrN2O2S: C 46.03, Н 3.27, N 8.26,S 9.45.Found: C 45.84, Н 3.25, N 8.23,S9.41.
2-([2-(3-Methoxyphenyl)-2-oxoethyl]thio)-6-methylpyrimidin-4(3H)-one (3.3).
Yield – 78%, m.p. = 173–5 °C.1HNMR (400 MHz, DMSO-d6): 12.52 (br. s, 1Н, NH-3), 7.61 (d, J 7.5 Hz, 1H, H-6’), 7.52 (s, 1H, H-2’), 7.41 (t, J 8.2 Hz, 1H, H-5’), 7.18 (d, J 7.5 Hz, 1H, H-4’), 5.97 (s, 1H, CH-5), 4.72 (s, 2H, SCH2), 3.85 (s, 3Н, ОСН3), 2.00 (s, 3H, CH3). Found, m/z: 291,07 [M+H]+.Anal. Calcd forC14H14N2O3S:C57.92, Н 4.86,N 9.65, S 11.04. Found: C 57.82, Н 4.84, N 9.62, S 11.00.
2-([2-(4-Methoxyphenyl)-2-oxoethyl]thio)-6-methylpyrimidin-4(3H)-one (3.4).
Yield – 78%,m.p. = 173–5 °C. 1HNMR (400 MHz, DMSO-d6): 12.52 (br. s, 1Н, NH-3), 8.03 (d, J 9 Hz, 2H, H-2’,6’), 7.06 (d, J 9 Hz, 2H, H-3’,5’), 5.95 (s, 1H, CH-5), 4.70 (s, 2H, SCH2), 3.86 (s, 3Н, ОСН3), 1,99 (s, 3H, CH3). Found, m/z: 291,07 [M+H]+.Anal. Calcd forC14H14N2O3S: C 57.92, Н 4.86, N 9.65,S 11.04. Found: C 57.84, Н 4.84, N 9.67,S 11.01.
2-([2-(4-Fluorophenyl)-2-oxoethyl]thio)-6-methylpyrimidin-4(3H)-one (3.5).
Yield – 78%, m.p. = 173–5 °C. 1HNMR (400 MHz, DMSO-d6): 12.52 (br. s, 1Н, NH-3), 8.03 (d, J 9 Hz, 2H, H-2’,6’), 7.06 (d,J 9 Hz, 2H, H-3’,5’), 5.95 (s, 1H, CH-5), 4.70 (s, 2H, SCH2), 1.99 (с, 3H, CH3). Found, m/z:279,02 [M+H]+.Anal. Calcd forC13H11FN2O2S: C 56.10, Н 3.98, N 10.07, S 11.52. Found: C 56.01, Н 3.96, N9.70,S 11.50.
2-([2-(4-Nitrophenyl)-2-oxoethyl]thio)-6-methylpyrimidin-4(3H)-one (3.6).
Yield – 74%, m.p. = 197–9 °C. 1HNMR (400 MHz, DMSO-d6): 12.50 (br. s, 1Н, NH-3), 8.12–8.08 (m, 2H, H-2’,6’), 7.23–7.18 (m, 2H, H-3’,5’), 5.84 (s, 1H, CH-5), 4.60 (s, 2H, SCH2), 2.04 (s, 3H, CH3). Found, m/z:306,05 [M+H]+. Anal. Calcd for C13H11N3O4S: C 51.14, Н 3.63, N 13.76, S 10.50. Found: C51.00, Н 3.62, N 13.78, S 10.48.
Benzyl [(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetate (3.7).
Yield – 75%, m.p. = 175–5 °C. 1HNMR (400 MHz, DMSO-d6): 12.55 (br. s, 1Н, NH-3), 7.42–7.22 (m, 5H, Ph), 5.96 (s, 1H, CH-5), 5.18 (s, 2H, SCH2), 4.01 (2H, с, OCH2), 2.05 (s, 3H, CH3). Found, m/z:291,2[M+H]+.Anal. Calcd forC14H14N2O3S: C57.92, Н 4.86,N 9.65, S 11.04. Found: C 57,87; Н 4.84, N 9.69, S 11.02.
General procedure for the synthesis of 7-methyl-3-aryl-5H-thiazolo[3,2-a]pyrimidin-5-one derivatives (5.1–5.4). A mixture of 7.34 mmol of 2-thiouracil 1 and 10.85 mmol of potassium carbonate in 10 mL of DMF was stirred at 70–80 °C. for 1 hour, the reaction mixture was cooled to room temperature, a solution of 7.34 mmol of the corresponding phenacyl bromide 2 in 10 mL of DMF was added, stirred for 3 hours (TLC). After cooling to room temperature, the reaction mixture was filtered and the filtrate was evaporated in vacuum; the residue was treated with 100 ml of cold water. The formed precipitate was filtered off, dried in air (mixture of products 3 and 4). Then to the precipitate was added 10 ml of sulphuric acid was left to stand for 24 hours at room temperature. The mixture was poured into cold water and neutralized with aqueous sodium hydroxide solution. The formed precipitate was filtered off, washed with water and dried.
3-Phenyl-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one (5.1).
Yield – 90%, m.p. = 126–8 °C. 1HNMR (400 MHz, DMSO-d6): 8.08 (d, J 7.5, 2H, H-2’,6’), 7.69–7.60 (m, 3H, H-2, H-3’,5’), 7,53 (t, J 7.5, 1H, H-4’), 6.07 (s, 1H, H-6), 2.20 (s, 3H, CH3). Found, m/z:243,2 [M+H]+.Anal. Calcd forC13H10N2OS: C64.44, Н 4.16, N 11.56, S 13.23. Found: 64.20. Н 4.14, N 11.59, S 13.18.
3-(4-Bromophenyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one (5.2)[19].
Yield – 93%, m.p. = 110–11 °C.1 HNMR (400 MHz, DMSO-d6): 7.75 (d, J8 Hz, 2H, H-2’,6’), 7.69 (s, 1H, H-2), 7.65 (d, J 8 Hz, 2H, H-3’,5’), 6.06 (s, 1H, H-6), 2.28 (s, 3H, CH3).Anal. CalcdforC13H9BrN2OS: C 48.61, Н 2.82, N 8.72, S 9.98.Found: C 48.48, Н 2.80, N 8.74, S9.95.
3-(3-Methoxyphenyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one (5.3).
Yield – 92%, m.p. = 114–6 °C. 1HNMR (400 MHz, DMSO-d6): 7.71 (d, J 7.5 Hz, 1H, H-6’), 7.69 (s, 1H, H-2), 7.50 (s, 1H, H-2’), 7,41 (t, J 8.2 Hz, 1H, H-5’), 7.18 (d, J 7.5, 1H, H-4’), 6.10 (s, 1H, H-6), 3.85 (s, 3Н, ОСН3), 1.99 (s, 3H, CH3). Anal. Calcdfor C14H12N2O2S: C 61.75, Н 4.44, N 10.29, S11.77. Found: C61.50, Н4.42, N10.31, S11.73.
3-(4-Methoxyphenyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one (5.4).
Yield – 93%, m.p. = 118–20 °C. 1HNMR (400 MHz, DMSO-d6): 8.03 (d, J 9 Hz, 2H, H-2’,6’), 7.69 (s, 1H, H-2), 7.06 (d, J 9 Hz, 2H, H-3’,5’), 6.11 (s, 1H, H-6), 3.85 (s, 3Н, ОСН3), 2.00 (s, 3H, CH3). Anal. CalcdforC14H12N2O2S: C 61.75, Н 4.44,N 10.29,S 11.77. Found:C 61.54, Н 4.43, N 10.33, S 11.76.
The studies were performed on 65 white non-linear male rats weighing 130–150 g. Animals were bred in a vivarium at the Vinnitsa National Medical University, which is named after M.I. Pirogov. During the study, the animals were under standard vivarium conditions with free access to water and food and 12 hours of light (8:00 to 20:00). All experiments were carried out in accordance with the “Directive 2010/63 / EC of the European Parliament and of the Council of Europe on September 22, 2010 on the protection of animals used for scientific purposes”, with the procedures and requirements of the State Expert Centre of the Ministry of Health of Ukraine and the rules of the European Convention on the protection of vertebrate animals used for experimental and other scientific purposes (Strasbourg, 1986), the Decree of the First National Congress on Bioethics (Kyiv, 2001), the National Congress of Ukraine on Bioethics (Kyiv, 2001) and Law of Ukraine No. 3447-IV “On protection of animals from cruel treatment” of 21.02.2006.
Animals were randomly assigned to experimental and control groups. The test substances were dissolved in 1% starch gel and injected with an oral cannula through a probe (volume 0.5 ml / 100 g body weight of rats). The screening dose for testing the compounds was 80 mg / kg. The reference compounds, phenobarbital and lamotrigine, were administered in the same way at their mean anticonvulsant doses of 20 mg / kg body weight, respectively (
The convulsive state in animals was modelled by single-dose subcutaneous administration of pentylenetetrazole (Sigma, USA) at a dose of 80 mg / kg. The manifestation of anticonvulsant activity was estimated by the dynamics of the latent period (from the introduction of the pentylenetetrazole to the start of the convulsions), the nature and duration of the trial in minutes, and the indicator of lethality. The intensity of convulsive attack was estimated using a 5-point scale, based on the following criteria (including the number of dead animals) (
Synthesis of the starting 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one 1 was carried out according to the known method (
In the literature (
It should be noted that the above-mentioned heterocyclic reaction was previously studied by scientists in the example of 2-[2-(4-bromophenyl)-2-oxoethyl] thio-pyrimidine-4(3H)-ones (
We did not see the need to divide the resulting mixture 3/4, instead we were interested in the possible effect of the condensed thiazole ring on anticonvulsant activity, as there are indications about the promising nature of thiazolopyrimidine derivatives as metabotropic glutamate receptor antagonists (
Influence of synthesized compounds 3.1–3.4, 3.7 and 5.1–5.4 on seizures induced by the administration of pentylenetrazole in rats.
Group of animals | Number of rats | Dose, mg/kg | Duration of latent period, min | Duration of seizures, min | Lethality abs. units | Intensity of seizures, (points) |
Control | 10 | 80 | 4.7 ± 0.30 | 9.70 ± 0.90 | 10 (100%) | 4.96 |
3.1 | 5 | 80 | 12.0 ± 1.8* | 12.4 ± 0.7 | 2 (40%) | 3.0 |
3.2 | 5 | 80 | 15.2 ± 1.2* | 11.6 ± 3.1 | 2 (40%) | 3.0 |
3.3 | 5 | 80 | 6.2 ± 1.8* | 8.2 ± 1.2 | 2 (40%) | 2.6 |
3.4 | 5 | 80 | 5.80 ± 1.0 | 17.8 ± 3.4* | 3 (60%) | 2.8 |
3.7 | 5 | 80 | 12.0 ± 1.6* | 15.4 ± 3.0 | 2 (40%) | 3.4 |
5.1 | 5 | 80 | 8.6 ± 0.5* | 15.0 ± 3.7* | 4 (80%) | 3.6 |
5.2 | 5 | 80 | 5.6 ± 0.4* | 8.4 ± 1.2 | 5 (100%) | 4.6 |
5.3 | 5 | 80 | 9.0 ± 1.5* | 18.6 ± 3.7* | 5 (100%) | 4.6 |
5.4 | 5 | 80 | 8.8 ± 1.1* | 12.6 ± 2.9 | 4 (80%) | 4.4 |
Phenobarbital | 5 | 20 | 30.0 | 0 | 0 | 0 |
Lamotrigine | 5 | 20 | 27.6 ± 0.8* | 2.40 ± 0.40* | 1 (20%) | 2.20 |
To obtain the targeted 2-[2-aryl-2-oxoethyl]thio-pyrimidine-4(3H)-ones, 3.1–3.6, we tried to change the alkylation conditions using methanol as a solvent and sodium methoxide as a catalyst without heating the reaction mixture. The reaction time was determined by thin-layer chromatography and was 1 hour. Under these conditions, we were able to obtain S - derivatives 3.1 in individual form with satisfactory yields and with sufficient purity, which is confirmed by the data of chromagraphic mass spectrometry.
Nine synthesized compounds from the groups of phenacyl derivatives and their cyclization products containing phenyl 3.1, 5.1, 4-bromophenyl 3.2, 5.2, 3-methoxy3.3, 5.3 and 4-methoxy-phenylene 3.4, 5.4, and benzyl acetate fragment 3.7 were considered on the anticonvulsant activity on the pentylenetrazole seizures models in rats. The choice of compounds for screening was based on the previously obtained data (
In the control group, the administration of pentylenetetrazole induced seizure in all animals. At the same time, the duration of the latent period of convulsions amounted to an average of 4.7 minutes, and the length of the trial - 9.7 minutes (Tab.
All investigated compounds did not show a significant anticonvulsant effect. In all studied groups of animals, seizures appeared after the administration of pentylenetrazole and the compounds studied, and significant lethality was observed (Tab.
In addition, it can be stated that compounds with condensed thiazolopyrimidine fragment 5.1–5.4 do not have an anticonvulsant effect in any of the indicators and do not protect the animals from death against the background of administration of pentylenetetrazole.
It was found that for the preparation of individual 2-(2-aryl-2-oxoethyl)thio-6-methyl-pyrimidin-4(3H)-one alkylation of 6-methyl-2-thioxo-2,3-dihydro-1H-pyrimidine-4-onеphenacyl bromides should be carried out in methanol in the presence of sodium methoxide. In the course of the alkylation in DMF/K2CO3 a mixture of 2-(2-aryl-2-oxoethyl)thio-6-methyl-pyrimidin-4(3H)-one and 3-hydroxy-3-aryl-7-methyl-5H-thiazolo[3,2-a]pyrimidine-5-ones, treatment of which with concentrated sulphuric acid allows to get 3-aryl-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one with high outputs. On the model of pentylenetrazole seizures in rats, in comparison with reference phenobarbital and lamotrigine, the synthesized compounds did not show significant anticonvulsant activity.